Journal
JOURNAL OF MOLECULAR ENDOCRINOLOGY
Volume 48, Issue 2, Pages R13-R29Publisher
BIOSCIENTIFICA LTD
DOI: 10.1530/JME-11-0145
Keywords
-
Categories
Funding
- Italian Ministry of Education, Universities and Research [IDEAS RBID08777T]
- Center for Laboratory Medicine
Ask authors/readers for more resources
Estrogens not only play a pivotal role in sexual development but are also involved in several physiological processes in various tissues including vasculature. While several epidemiological studies documented an inverse relationship between plasma estrogen levels and the incidence of cardiovascular disease and related it to the inhibition of atherosclerosis, an interventional trial showed an increase in cardiovascular events among postmenopausal women on estrogen treatment. The development of atherosclerotic lesions involves complex interplay between various pro- or anti-atherogenic processes that can be effectively studied only in vivo in appropriate animal models. With the advent of genetic engineering, transgenic mouse models of atherosclerosis have supplemented classical dietary cholesterol-induced disease models such as the cholesterol-fed rabbit. In the last two decades, these models were widely applied along with in vitro cell systems to specifically investigate the influence of estrogens on the development of early and advanced atherosclerotic lesions. The present review summarizes the results of these studies and assesses their contribution toward better understanding of molecular mechanisms underlying anti- and/or pro- atherogenic effects of estrogens in humans. Journal of Molecular Endocrinology (2012) 48, R13-R29
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available